Literature DB >> 29526650

miRNAs Targeting ICP4 and Delivered to Susceptible Cells in Exosomes Block HSV-1 Replication in a Dose-Dependent Manner.

Lei Wang1, Xiaoqing Chen2, Xusha Zhou1, Bernard Roizman3, Grace Guoying Zhou4.   

Abstract

miRNAs are potent tools that in principle can be used to control the replication of infectious agents. The objectives of the studies reported here were to design miRNAs that can block the replication of herpes simplex virus 1 and which could be delivered to infected cells via exosomes. We report the following: (1) We designed three miRNAs targeting the mRNA encoding ICP4, an essential viral regulatory protein. Of the three miRNAs, one miRNA401 effectively blocked ICP4 accumulation and viral replication on transfection into susceptible cells. (2) To facilitate packaging of the miRNA into exosomes, we incorporated into the sequence of miRNA401 an exosome-packaging motif. miRNA401 was shown to be packaged into exosomes and successfully delivered by exosomes to susceptible cells, where it remained stable for at least 72 hr. Finally, the results show that miRNA401 delivered to cells via exosomes effectively reduced virus yields in a miRNA401 dose-dependent fashion. The protocol described in this report can be applied to study viral gene functions without actually deleting or mutagenizing the gene.
Copyright © 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HSV-1; exosome; target miRNA; viral replication

Mesh:

Substances:

Year:  2018        PMID: 29526650      PMCID: PMC6080130          DOI: 10.1016/j.ymthe.2018.02.016

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  47 in total

1.  A predictive model for DNA recognition by the herpes simplex virus protein ICP4.

Authors:  J A DiDonato; J R Spitzner; M T Muller
Journal:  J Mol Biol       Date:  1991-06-05       Impact factor: 5.469

2.  Binding of the virion protein mediating alpha gene induction in herpes simplex virus 1-infected cells to its cis site requires cellular proteins.

Authors:  J L McKnight; T M Kristie; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

3.  DNA binding and gene regulation by the herpes simplex virus type 1 protein ICP4 and involvement of the TATA element.

Authors:  J A DiDonato; M T Muller
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

4.  hnRNP A2 selectively binds the cytoplasmic transport sequence of myelin basic protein mRNA.

Authors:  K S Hoek; G J Kidd; J H Carson; R Smith
Journal:  Biochemistry       Date:  1998-05-12       Impact factor: 3.162

5.  Preparation of herpes simplex virus of high titer.

Authors:  B Roizman; P G Spear
Journal:  J Virol       Date:  1968-01       Impact factor: 5.103

6.  Repression of the herpes simplex virus 1 alpha 4 gene by its gene product (ICP4) within the context of the viral genome is conditioned by the distance and stereoaxial alignment of the ICP4 DNA binding site relative to the TATA box.

Authors:  R Leopardi; N Michael; B Roizman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

7.  Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.

Authors:  Hadi Valadi; Karin Ekström; Apostolos Bossios; Margareta Sjöstrand; James J Lee; Jan O Lötvall
Journal:  Nat Cell Biol       Date:  2007-05-07       Impact factor: 28.824

8.  Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation.

Authors:  Angélique Bobrie; Marina Colombo; Sophie Krumeich; Graça Raposo; Clotilde Théry
Journal:  J Extracell Vesicles       Date:  2012-04-16

Review 9.  Exosome and exosomal microRNA: trafficking, sorting, and function.

Authors:  Jian Zhang; Sha Li; Lu Li; Meng Li; Chongye Guo; Jun Yao; Shuangli Mi
Journal:  Genomics Proteomics Bioinformatics       Date:  2015-02-24       Impact factor: 7.691

Review 10.  Role of exosomal proteins in cancer diagnosis.

Authors:  Weihua Li; Chuanyun Li; Tong Zhou; Xiuhong Liu; Xiaoni Liu; Xiuhui Li; Dexi Chen
Journal:  Mol Cancer       Date:  2017-08-29       Impact factor: 27.401

View more
  7 in total

1.  Varicella-Zoster Virus (VZV) Small Noncoding RNAs Antisense to the VZV Latency-Encoded Transcript VLT Enhance Viral Replication.

Authors:  Punam Bisht; Biswajit Das; Paul R Kinchington; Ronald S Goldstein
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

2.  hnRNPA2B1 Associated with Recruitment of RNA into Exosomes Plays a Key Role in Herpes Simplex Virus 1 Release from Infected Cells.

Authors:  Xusha Zhou; Lei Wang; Weixuan Zou; Xiaoqing Chen; Bernard Roizman; Grace Guoying Zhou
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

Review 3.  Cloaked Viruses and Viral Factors in Cutting Edge Exosome-Based Therapies.

Authors:  Christos Dogrammatzis; Hope Waisner; Maria Kalamvoki
Journal:  Front Cell Dev Biol       Date:  2020-05-26

4.  Plasma Exosomal Proteomic Pattern of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.

Authors:  Yan Xie; Li Yang; Pengfei Cao; Shen Li; Wentao Zhang; Wei Dang; Shuyu Xin; Mingjuan Jiang; Yujie Xin; Jing Li; Sijing Long; Yiwei Wang; Senmiao Zhang; Yang Yang; Jianhong Lu
Journal:  Front Microbiol       Date:  2022-04-06       Impact factor: 5.640

Review 5.  Involvement of host microRNAs in flavivirus-induced neuropathology: An update.

Authors:  Atreye Majumdar; Anirban Basu
Journal:  J Biosci       Date:  2022       Impact factor: 2.795

Review 6.  Immune Response to Herpes Simplex Virus Infection and Vaccine Development.

Authors:  Anthony C Ike; Chisom J Onu; Chukwuebuka M Ononugbo; Eleazar E Reward; Sophia O Muo
Journal:  Vaccines (Basel)       Date:  2020-06-12

7.  Exosomes containing miRNAs targeting HER2 synthesis and engineered to adhere to HER2 on tumor cells surface exhibit enhanced antitumor activity.

Authors:  Lei Wang; Xusha Zhou; Weixuan Zou; Yinglin Wu; Jing Zhao; Xiaoqing Chen; Grace Guoying Zhou
Journal:  J Nanobiotechnology       Date:  2020-10-27       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.